相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
Damien Bertheloot et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
Naoki Horikawa et al.
CLINICAL CANCER RESEARCH (2017)
ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition
H. J. Min et al.
MUCOSAL IMMUNOLOGY (2017)
Second-Line Chemotherapy and Beyond for Non-Small Cell Lung Cancer
Greg Durm et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
Akash Patnaik et al.
CANCER DISCOVERY (2017)
Role of CXC group chemokines in lung cancer development and progression
Artjoms Spaks
JOURNAL OF THORACIC DISEASE (2017)
CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF--mTOR-HIF-1 signaling in patients with non-small cell lung cancer
Jieyao Li et al.
ONCOIMMUNOLOGY (2017)
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer
Rui Kang et al.
CELL RESEARCH (2017)
Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration
Khayal Al-Khayal et al.
BMC CANCER (2017)
CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
Zuqiang Liu et al.
ONCOIMMUNOLOGY (2016)
Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
Jitka Fucikova et al.
CANCER RESEARCH (2016)
Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer
Hee Jin Lee et al.
PATHOLOGY INTERNATIONAL (2016)
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy
Ruth Exner et al.
CANCER MEDICINE (2016)
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial
K. Kubota et al.
ANNALS OF ONCOLOGY (2015)
CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma
J. Y. Liu et al.
BRITISH JOURNAL OF CANCER (2015)
HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway
Weijun Liu et al.
CANCER BIOLOGY & THERAPY (2015)
Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents
Takehito Shukuya et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood
Zhen Zhang et al.
CYTOTHERAPY (2015)
TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms
Wei Bin Fang et al.
PLOS ONE (2015)
Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
Peter S. Fenwick et al.
PLOS ONE (2015)
Macrophage Inflammatory Protein Derivative ECI301 Enhances the Alarmin-Associated Abscopal Benefits of Tumor Radiotherapy
Shiro Kanegasaki et al.
CANCER RESEARCH (2014)
IL-6 Trans-Signaling Enhances CCL20 Production from IL-1β-Stimulated Human Periodontal Ligament Cells
Yoshitaka Hosokawa et al.
INFLAMMATION (2014)
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
Banzhou Pan et al.
MOLECULAR CANCER (2014)
Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11
Hong Namkoong et al.
VACCINE (2014)
Tissue Damage-Associated Danger Signals Influence T-cell Responses That Promote the Progression of Preneoplasia to Cancer
Ying He et al.
CANCER RESEARCH (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer
Tobias Arnold et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
James W. Hodge et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Regulation of CCL20 expression in astrocytes by IL-6 and IL-17
Gordon P. Meares et al.
GLIA (2012)
The IKKα-Dependent NF-κB p52/RelB Noncanonical Pathway Is Essential To Sustain a CXCL12 Autocrine Loop in Cells Migrating in Response to HMGB1
Richard R. Kew et al.
JOURNAL OF IMMUNOLOGY (2012)
The Expression of High Mobility Group Box 1 is Associated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma
Chen Chuangui et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Apicidin and Docetaxel Combination Treatment Drives CTCFL Expression and HMGB1 Release Acting as Potential Antitumor Immune Response Inducers in Metastatic Breast Cancer Cells
Maria Buoncervello et al.
NEOPLASIA (2012)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Tumor Ablation by Gene-Modified T Cells in the Absence of Autoimmunity
Leanne X. J. Wang et al.
CANCER RESEARCH (2010)
CXC Chemokine Ligand (CXCL) 9 and CXCL10 Are Antagonistic Costimulation Molecules during the Priming of Alloreactive T Cell Effectors
Joshua M. Rosenblum et al.
JOURNAL OF IMMUNOLOGY (2010)
Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases
Daniel Mitchell et al.
MOLECULAR IMMUNOLOGY (2010)
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells
Lara Campana et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Combination of docetaxel and recombinant vaccine enhances T-Cell responses and antitumor activity: Effects of docetaxel on immune enhancement
Charlie T. Garnett et al.
CLINICAL CANCER RESEARCH (2008)
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Stanimir Ivanov et al.
BLOOD (2007)
Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus
Hyun A. Yoon et al.
IMMUNOLOGY (2007)
The secretion of HMGB1 is required for the migration of maturing dendritic cells
Ingrid E. Dumitriu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization
D Messmer et al.
JOURNAL OF IMMUNOLOGY (2004)
Taxane-platinum combinations in advanced non-small cell lung cancer: A review
JR Rigas
ONCOLOGIST (2004)
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors
NM Haynes et al.
BLOOD (2002)
Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL
PK Darcy et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
